PhRMA pitches pricing ideas to Price

HHS Secretary Tom Price held a “listening session” on drug pricing Friday with representatives of PhRMA; the Association for Accessible Medicines, which represents generic drug companies; and other stakeholders. In a statement following the session, PhRMA President and CEO Stephen Ubl said the trade association expressed its "commitment to working with the Administration to advance market-based reforms, such as addressing barriers to value-based payment arrangements, enhancing generic competition and ensuring patients benefit from the discounts and rebates negotiated by payers.”...